PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type - PubMed (original) (raw)

PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type

L S McDaniel et al. Infect Immun. 1991 Jan.

Abstract

Monoclonal antibodies against pneumococcal surface protein A (PspA) have been shown to protect mice from fatal pneumococcal infection. PspA is highly variable serologically, raising the possibility that PspA from one strain might not be able to elicit protective responses against strains which possess serologically different PspA. We have prepared a lambda gt11 library of pneumococcal genomic DNA and identified a clone expressing PspA. The recombinant PspA in this phage lysate elicited protection against pneumococcal infections with three strains of two different capsular serotypes. This finding demonstrated that PspA could elicit a protective response in the absence of other pneumococcal antigens. The observed protection was probably antibody mediated because it could be passively transferred with immune sera. Lambda lysates producing pneumococcal proteins other than PspA failed to elicit protection against fatal pneumococcal infection.

PubMed Disclaimer

Cited by

A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.
Uraki R, Piao Z, Akeda Y, Iwatsuki-Horimoto K, Kiso M, Ozawa M, Oishi K, Kawaoka Y. Uraki R, et al. J Infect Dis. 2015 Dec 15;212(12):1939-48. doi: 10.1093/infdis/jiv341. Epub 2015 Jun 29. J Infect Dis. 2015. PMID: 26123562 Free PMC article.
Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC. Chen A, et al. Clin Vaccine Immunol. 2015 Oct;22(10):1079-89. doi: 10.1128/CVI.00293-15. Epub 2015 Aug 5. Clin Vaccine Immunol. 2015. PMID: 26245351 Free PMC article.
A 43-kilodalton pneumococcal surface protein, PspA: isolation, protective abilities, and structural analysis of the amino-terminal sequence.
Talkington DF, Crimmins DL, Voellinger DC, Yother J, Briles DE. Talkington DF, et al. Infect Immun. 1991 Apr;59(4):1285-9. doi: 10.1128/iai.59.4.1285-1289.1991. Infect Immun. 1991. PMID: 2004810 Free PMC article.
Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2.
Wortham C, Grinberg L, Kaslow DC, Briles DE, McDaniel LS, Lees A, Flora M, Snapper CM, Mond JJ. Wortham C, et al. Infect Immun. 1998 Apr;66(4):1513-20. doi: 10.1128/IAI.66.4.1513-1520.1998. Infect Immun. 1998. PMID: 9529075 Free PMC article.
Streptococcus pneumoniae Cell-Wall-Localized Phosphoenolpyruvate Protein Phosphotransferase Can Function as an Adhesin: Identification of Its Host Target Molecules and Evaluation of Its Potential as a Vaccine.
Mizrachi Nebenzahl Y, Blau K, Kushnir T, Shagan M, Portnoi M, Cohen A, Azriel S, Malka I, Adawi A, Kafka D, Dotan S, Guterman G, Troib S, Fishilevich T, Gershoni JM, Braiman A, Mitchell AM, Mitchell TJ, Porat N, Goliand I, Chalifa Caspi V, Swiatlo E, Tal M, Ellis R, Elia N, Dagan R. Mizrachi Nebenzahl Y, et al. PLoS One. 2016 Mar 18;11(3):e0150320. doi: 10.1371/journal.pone.0150320. eCollection 2016. PLoS One. 2016. PMID: 26990554 Free PMC article.

References

1. J Exp Med. 1981 Mar 1;153(3):694-705 - PubMed
1. J Immunol. 1979 Oct;123(4):1548-50 - PubMed
1. Infect Immun. 1983 May;40(2):548-52 - PubMed
1. J Clin Microbiol. 1983 Nov;18(5):1102-7 - PubMed
1. J Exp Med. 1984 Aug 1;160(2):386-97 - PubMed

PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type - PubMed (original) (raw)